Clinical Trial Update: Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy [NA]

View source ↗

Summary

Clinical trial update assessing a 660 nm laser to prevent radiodermatitis in breast cancer patients undergoing radiation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Universidade do Vale do Sapucai | Conditions: Radiotherapy; Adverse Effect, Dermatitis or Eczema, Breast Neoplasms | NA | Status: COMPLETED